Skip to main content

Blackstone to Create Compute Farm for Biogen

NEW YORK, Nov 1 – Blackstone Technology Group announced Wednesday that it will build a large-scale, distributed compute farm system for Biogen.

Financial terms of the deal were not disclosed. 

Blackstone will provide a high-performance compute farm based on the Linux operating system and Intel-based processors to support Biogen's drug discovery efforts. The Linux farm will interoperate with Biogen's existing Unix infrastructure, which consists of Sun hardware running Solaris and SGI hardware running Irix.

Biogen will receive Blackstone's SmartBlast tool for distributing computationally-intensive genomic applications across compute farms and its SmartCache data management tool to speed data flow across the farm.

The biotech company will also get Blackstone's SmartWatch software to monitor CPU usage rates and efficiency levels as well as LSF load-balancing software from Platform Computing, which optimizes processing across CPUs in the compute farm.

Ron Ranauro, founder and chief executive officer of Blackstone, said, “We're very excited that Biogen selected us to work with them to build a fast and efficient computing platform to speed their drug discovery.”

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.